VS

Vineet Satyanarain Sankhla

Director Director DIN 08423122
DIN 08423122 First appointment Apr 2019 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Vineet Satyanarain Sankhla

Data last updated:

Vineet Satyanarain Sankhla was a Director at Curigo Pharmaceuticals Private Limited (2020–2022) and Designated Partner at Neoterizo Healthcare Llp (from 2019). The companies operate in Pharma.

DIN 08423122
Primary Designation Director
Industry Pharma
First Appointment 16 Apr 2019
Oldest Company Age 7 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Jun 20202020₹45.2 Lakh (FY 2025)Active
Designated Partner16 Apr 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Neoterizo Healthcare Llp
Curigo Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vineet Satyanarain Sankhla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vineet Satyanarain Sankhla

Vineet Satyanarain Sankhla was first appointed on 16 Apr 2019 as Designated Partner at Neoterizo Healthcare Llp. The most recent appointment on record is 09 Jun 2020 at Curigo Pharmaceuticals Private Limited.

Vineet Satyanarain Sankhla held 2 earlier board appointments: Curigo Pharmaceuticals Private Limited (Director, 09 Jun 2020 to 28 Mar 2022); Neoterizo Healthcare Llp (Designated Partner, from 16 Apr 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available